http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35507939

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
issn 2235-2988
pageRange 1178788-
publicationName Frontiers in Cellular and Infection Microbiology
startingPage 1178788
bibliographicCitation Li X, Xu L, Lu L, Liu X, Yang Y, Wu Y, Han Y, Li X, Li Y, Song X, Cao W, Li T. CD4+ T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy. Front Cell Infect Microbiol. 2023;13():1178788. PMID: 37207191; PMCID: PMC10189149.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd264243594e48a04c5ce9e15ada6930
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bde14b477a1c47e596a60edf441f835d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e10fb4c353eb7e695bdeac02471372b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aef6b0c1a413f9d2bb03b6283fc43093
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb4f851739cda474f9048e785cf3e727
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cfb820838b17405d3494ae29efac32c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9b9c92f6b50960b20d850f197baeb90
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d833cf38560f113304b358e087d16f9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7883199d46b49cdb98ff67e5ca3ba441
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47e8fd2704a1df299c6e6c7a1d6606b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0bb2d3784e3a18967d410ee608602e9
date 2023-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.3389/fcimb.2023.1178788
https://pubmed.ncbi.nlm.nih.gov/PMC10189149
https://pubmed.ncbi.nlm.nih.gov/37207191
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40476
https://portal.issn.org/resource/ISSN/2235-2988
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title CD4+ T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy
discusses http://id.nlm.nih.gov/mesh/M0010217
http://id.nlm.nih.gov/mesh/M0006695
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D006509Q000150
http://id.nlm.nih.gov/mesh/D006509Q000188
http://id.nlm.nih.gov/mesh/D015658Q000188
http://id.nlm.nih.gov/mesh/D060085
http://id.nlm.nih.gov/mesh/D015658Q000150
hasSubjectTerm http://id.nlm.nih.gov/mesh/D018655
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004279
http://id.nlm.nih.gov/mesh/D006515Q000235
http://id.nlm.nih.gov/mesh/D015496
http://id.nlm.nih.gov/mesh/D006514
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6fab6bf193c862d5cac8dd80e83ceb7a
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8154
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765

Total number of triples: 48.